Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

1126

1

ArriVent Biopharma, Inc. ArriVent Biopharma Reports $80.5 Million Net Loss for 2024, Increases R&D Spending

Via official filing (AI summary) | 28 days ago | 0 comments

1127

1

OCULAR THERAPEUTIX, INC Ocular Therapeutix Reports $193.5 Million Net Loss for 2024, Increases DEXTENZA Sales by 9.7%

Via official filing (AI summary) | 28 days ago | 0 comments

1128

1

Hut 8 Corp. Hut 8 Corp. Reports $162.4 Million Revenue and $331.9 Million Net Income for 2024

Via official filing (AI summary) | 28 days ago | 0 comments

1129

1

Apogee Therapeutics, Inc. Apogee Therapeutics Reports $182.1 Million Net Loss for Year Ended December 31, 2024

Via official filing (AI summary) | 28 days ago | 0 comments

1130

1

REDWOOD TRUST INC Redwood Trust Reports $54M Net Income for 2024, Significant Revenue Increases

Via official filing (AI summary) | 28 days ago | 0 comments

1131

1

Atea Pharmaceuticals, Inc. Atea Pharmaceuticals Reports $168.4 Million Net Loss for 2024, Plans Phase 3 Trials for HCV Treatment

Via official filing (AI summary) | 29 days ago | 0 comments

1132

1

KINETA, INC./DE Kineta, Inc. Reports $17.1 Million Net Loss and Explores Strategic Alternatives Amid Financial Challenges

Via official filing (AI summary) | 29 days ago | 0 comments

1133

1

Bancorp 34, Inc. Bancorp 34 Reports $1.7 Million Net Income for 2024 After CBOA Merger

Via official filing (AI summary) | 29 days ago | 0 comments

1134

1

ModivCare Inc ModivCare Reports $201.3 Million Net Loss and 1.3% Revenue Growth for 2024

Via official filing (AI summary) | 29 days ago | 0 comments

1135

1

EVgo Inc. EVgo Inc. Reports 60% Revenue Growth to $256.8 Million for 2024

Via official filing (AI summary) | 29 days ago | 0 comments

1136

1

SYNLOGIC, INC. Synlogic Reports $23.36 Million Net Loss for Fiscal Year 2024, Revenue Drops to $8,000

Via official filing (AI summary) | 29 days ago | 0 comments

1137

1

ALX ONCOLOGY HOLDINGS INC ALX Oncology Reports $134.85 Million Net Loss for 2024, Highlights Evorpacept Clinical Trials

Via official filing (AI summary) | 29 days ago | 0 comments

1138

1

Elevation Oncology, Inc. Elevation Oncology Reports $44.5 Million Net Loss for 2024, Highlights EO-3021 Clinical Trial Success

Via official filing (AI summary) | 29 days ago | 0 comments

1139

1

Cidara Therapeutics, Inc. Cidara Therapeutics Reports $169.8 Million Net Loss and Decreased Collaboration Revenue in 2024

Via official filing (AI summary) | 29 days ago | 0 comments

1140

1

Foghorn Therapeutics Inc. Foghorn Therapeutics Reports $86.6 Million Net Loss for 2024, Decreased Collaboration Revenue

Via official filing (AI summary) | 29 days ago | 0 comments

1141

1

Contineum Therapeutics, Inc. Contineum Therapeutics Reports $42.26 Million Net Loss for 2024

Via official filing (AI summary) | 29 days ago | 0 comments

1142

1

FIDUS INVESTMENT Corp Fidus Investment Corporation Reports 12.3% Increase in Total Investment Income for 2024

Via official filing (AI summary) | 29 days ago | 0 comments

1143

1

IGM Biosciences, Inc. IGM Biosciences Reports $195.8 Million Net Loss for 2024, Focuses on Immunology

Via official filing (AI summary) | 29 days ago | 0 comments

1144

1

TerrAscend Corp. TerrAscend Corp. Reports $72.7 Million Net Loss and $306.7 Million Revenue for 2024

Via official filing (AI summary) | 29 days ago | 0 comments

1145

1

Adicet Bio, Inc. Adicet Bio Reports $117.1 Million Net Loss for 2024, FDA Clears IND Applications for ADI-001 and ADI-270

Via official filing (AI summary) | 29 days ago | 0 comments

1146

1

CytomX Therapeutics, Inc. CytomX Therapeutics Reports $138.1 Million Revenue for 2024, Driven by Collaborations

Via official filing (AI summary) | 29 days ago | 0 comments

1147

1

AMERICAN PUBLIC EDUCATION INC American Public Education Reports 4% Revenue Growth to $624.6 Million for 2024

Via official filing (AI summary) | 29 days ago | 0 comments

1148

1

Black Diamond Therapeutics, Inc. Black Diamond Therapeutics Reports $69.7 Million Net Loss for 2024, Highlights Progress in BDTX-1535 Trials

Via official filing (AI summary) | 29 days ago | 0 comments

1149

1

Comstock Inc. Comstock Inc. Reports $53.4 Million Net Loss Despite Revenue Growth to $3.0 Million in 2024

Via official filing (AI summary) | 29 days ago | 0 comments

1150

1

Paragon 28, Inc. Paragon 28 Reports 18% Revenue Growth to $256.2 Million in 2024

Via official filing (AI summary) | 29 days ago | 0 comments